NCT03756389View on ClinicalTrials.gov

Evaluation of Topical Application of BMX-010 in Subjects With Rosacea

PHASE2SuspendedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

January 3, 2018

Primary Completion Date

September 30, 2024

Study Completion Date

March 31, 2025

Conditions

Rosacea

Interventions

DRUG

BMX-010

Safety and efficacy of BMX-010 in topical treatment of rosacea.

Trial Locations (1)

80113

Colorado Skin Care, Englewood

Sponsors

Lead Sponsor

BioMimetix JV, LLC

All Listed Sponsors

lead

BioMimetix JV, LLC

INDUSTRY

NCT03756389 - Evaluation of Topical Application of BMX-010 in Subjects With Rosacea | Biotech Hunter | Biotech Hunter